AQST
NASDAQ · Pharmaceuticals
Aquestive Therapeutics Inc
$3.61
-0.05 (-1.37%)
Open$3.71
Previous Close$3.66
Day High$3.76
Day Low$3.55
52W High$6.85
52W Low$2.93
Volume—
Avg Volume2.02M
Market Cap451.85M
P/E Ratio—
EPS$-0.65
SectorPharmaceuticals
Analyst Ratings
Strong Buy
15 analysts
Price Target
+617.5% upside
Current
$3.61
$3.61
Target
$25.90
$25.90
$17.61
$25.90 avg
$34.98
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 49.93M | 51.08M | 128.94M |
| Net Income | -93,917,120 | -86,462,160 | 33.13M |
| Profit Margin | -188.1% | -178.7% | 25.7% |
| EBITDA | -79,031,328 | -76,800,083 | 53.66M |
| Free Cash Flow | — | — | 23.71M |
| Rev Growth | -2.2% | -2.2% | +19.1% |
| Debt/Equity | 4.68 | 4.68 | 0.57 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |